Skip to content

Clinical trials

Observational Recurrence trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Observational Country / region: South Korea Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20091
20111
20142
20162
20173
20181
20191
20201
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting4
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center5
Asan Medical Center2
Celgene2
Sung-Soo Park2
Astellas Pharma Korea, Inc.1
Astellas Pharma Singapore Pte. Ltd.1
AstraZeneca1
Korean Association of Endocrine Surgeons1
Severance Hospital1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence18
Leukemia, Myeloid, Acute2
Multiple Myeloma2
Atrial Fibrillation1
Autoimmune Pancreatitis1
Brain Neoplasms1
Breast Neoplasms1
Burkitt Lymphoma1
Carcinoma, Non-Small-Cell Lung1
Hodgkin Disease1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.